Preclinical study points to cancer drugs as possible treatments for chronic nerve pain

Researchers at The University of Texas MD Anderson Cancer Center have found new evidence that BRAF, a protein commonly involved in cancer, plays a key role in developing, amplifying and maintaining chronic pain caused by nerve damage. BRAF inhibitors reduced pain sensitivity in preclinical models, suggesting the therapeutic potential of this approach for treating chronic nerve pain.

Read it at Medical Xpress ↗

← Front page